🇺🇸 Innovative Valganciclovir in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Innovative Valganciclovir on 28 August 2009

Marketing authorisation

FDA — authorised 28 August 2009

Application: NDA022257
Marketing authorisation holder: CHEPLAPHARM
Local brand name: VALCYTE
Indication: FOR SOLUTION — ORAL
Status: approved

Read official source →

Frequently asked questions

Is Innovative Valganciclovir approved in United States?

Yes. FDA authorised it on 28 August 2009.

Who is the marketing authorisation holder for Innovative Valganciclovir in United States?

CHEPLAPHARM holds the US marketing authorisation.